We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · December 09, 2021

Time to Benefit of Bisphosphonate Therapy for the Prevention of Fractures Among Postmenopausal Women With Osteoporosis

JAMA Internal Medicine

 

Additional Info

Disclosure statements are available on the authors' profiles:

JAMA Internal Medicine
Time to Benefit of Bisphosphonate Therapy for the Prevention of Fractures Among Postmenopausal Women With Osteoporosis: A Meta-analysis of Randomized Clinical Trials
JAMA Intern Med 2021 Nov 22;[EPub Ahead of Print], WJ Deardorff, I Cenzer, B Nguyen, SJ Lee

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading